Traws Pharma, Inc.TRAWNASDAQ

Revenue (LTM)

$226000

+0.0% YoY

Net Income (LTM)

$-55M

-188.5% YoY

Free Cash Flow

$-30M

Revenue CAGR (5Y)

-36.5%

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0↓2.2%	0↓0.0%	0↓0.0%	0↓0.0%
Gross Profit	0	0↓2.2%	0↓0.0%	0↓0.0%	0↓5.3%
Operating Income	-25	-16↑34.0%	-20↓19.0%	-20↓3.4%	-49↓143.1%
Net Income	-25	-16↑35.8%	-19↓17.3%	-19↑0.1%	-55↓188.5%
EBITDA	-25	-16↑34.0%	-20↓19.0%	-20↓3.4%	-167↓721.0%
EPS Diluted	-54.21	-24.01↑55.7%	-22.68↑5.5%	-22.57↑0.5%	-35.21↓56.0%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	19	55↑189.5%	39↓29.6%	21↓46.3%	21↑2.5%
Total Current Assets	20	55↑180.2%	39↓29.0%	23↓42.4%	25↑10.1%
Total Assets	20	55↑177.6%	39↓29.0%	23↓42.4%	25↑10.0%
Total Current Liabilities	10	6↓39.0%	8↑31.6%	9↑14.6%	12↑25.1%
Total Liabilities	14	9↓32.2%	11↑18.2%	12↑8.6%	57↑371.2%
Total Equity	6	46↑646.9%	28↓38.6%	11↓62.3%	-32↓396.4%
Total Debt	0	0	0	0	0
Net Debt	-19	-55↓189.5%	-39↑29.6%	-21↑46.3%	-21↓2.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-23	-19↑15.5%	-16↑16.4%	-18↓10.1%	-30↓66.1%
Capital Expenditure	-0	0	0	-0	0
Free Cash Flow	-23	-19↑15.6%	-16↑16.4%	-18↓10.1%	-30↓66.0%
Stock-Based Comp	0	1	1↑103.5%	1↑11.0%	0
Net Change in Cash	-4	36↑1073.9%	-16↓145.3%	-18↓9.9%	1↑102.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance